Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,116.17 +16.21 (+0.32%) Dow
38,386.09 +146.43 (+0.38%) Nasdaq
15,983.08 +55.18 (+0.35%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,273.77 -65.29 (-4.88%)
LLY Jan 2025 250.000 call
- Yahoo Finance Video
Why these analysts are bullish on healthcare stocks
The healthcare sector has underperformed throughout 2024, but as the first quarter earnings season unfolds, Jefferies Healthcare Services Equity Research Analyst Brian Tanquilut and Grey Ghost Advisors Private Equity Investor Meghan Fitzgerald join Market Domination to discuss how investors should position themselves in this market. Fitzgerald remains bullish on the healthcare sector, believing it still has "a lot of long and important tailwinds." She cites the sector's historical outperformance during market downturns and election years as reasons for her optimism. Fitzgerald anticipates strong earnings from companies with GLP-1 drug portfolios this week, describing it as an "easy beat." Tanquilut notes a "rise in broader healthcare utilization trends," which is now reflected in healthcare insurers' earnings. While there has been weakness in this area, he highlights the "strength in volume" from healthcare providers. However, Tanquilut acknowledges that with consumer spending slowing, consumer-focused healthcare segments, such as drugstores, have experienced pressure. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. Editor's note: This article was written by Angel Smith
- Yahoo Finance
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
The latest GLP-1 drugs are starting to see proof of greater use beyond diabetes and obesity. How will it affect makers Novo Nordisk and Eli Lilly?
- Reuters
US STOCKS-Futures drift lower as focus turns to upcoming Fed meet
Futures tracking Wall Street's main indexes were subdued on Tuesday as investors refrained from placing big bets ahead of the Federal Reserve's interest rate decision and kept a close eye on a stream of earnings updates. The Federal Reserve Open Market Committee (FOMC) will commence its two-day meeting later in the day, with markets focused on the interest rate verdict and Chair Jerome Powell's remarks. Money markets are largely expecting the central bank to stand pat on interest rates this meeting, while pricing in just about 35 basis points (bps) of rate cuts this year, down from about 150 bps estimated at the start of 2024, according to LSEG data.
